The information to be found in this section is intended for the exclusive use of healthcare professionals.
Anti-phospoholid syndrome: anti-Cardiolipin IgM
Quantitative determination of the specific β2-glycoprotein I dependent anti-cardiolipin IgM antibodies in samples of human serum or plasma
Number of tests:
Serum or plasma (EDTA, Heparin)
10 + 10 minutes
Stability of calibration:
Cartridge stability on board:
0-640 MPL U/ml.
Negative < 10 | Positive ≥ 10
Clinical sensitivity :
Limit of detection:
6.8 MPL U/ml
Intra-assay CV% ≤ 6,7% | Inter-assay CV% ≤ 9,3%
Relative sensitivity§ :
*The content of this file is for informational purposes only. The latest, updated version of the IFU, to which you should always refer, is the one accompanying the product and is to be found on the disk inside the product kit